Cardioneuroablation for Reflex Syncope and Exercise Capacity
Recruiting
N/A
Interventional Study
Syncope, Vasovagal
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Centre of Postgraduate Medical Education · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cardioneuroablation (CNA) is a new promising method to treat reflex syncope which is due to vagally-induced functional sinus arrest or atrio-ventricular block (AVB). Although the procedure is effective in \> 80% of patients, there are potential adverse effects associated with the lack of vagal protection. One of them is increased sinus rate and possible worsening of exercise capacity. However, it …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* severe, recurrent symptoms due to reflex syncope or recurrent presyncope due to slow heart rate
* ECG documented asystole \>3 seconds
* ineffective prior non-pharmacological treatment
* positive baseline atropine test (sinus rate acceleration \> 30% and no atrio-ventricular bl…
Contacts